{
    "nctId": "NCT04560699",
    "briefTitle": "Targeted Physiotherapeutic Treatment for Aromatase Inhibitor-associated Musculoskeletal Pain in Breast Cancer Survivors",
    "officialTitle": "Targeted Physiotherapeutic Treatment for Aromatase Inhibitor-associated Musculoskeletal Pain in Breast Cancer Survivors: a Randomized Controlled Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Musculoskeletal Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 111,
    "primaryOutcomeMeasure": "Change in Brief pain inventory (BPI)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adequately treated primary invasive breast cancer with surgery (breast conserving surgery or mastectomy) and radiotherapy if applicable\n* Estrogen receptor positive tumor with staining of \u226510% tumorcells\n* Aromatase inhibitor treatment\n* Perceived musculoskeletal pain in the upper or lower extremities attributable to AI treatment for at least 2 month and a maximum of 24 months\n* Age \u226518\n* Willing and able to understand and participate in the study\n\nExclusion Criteria:\n\n* Locally advanced breast cancer or distant metastases\n* Lymphedema\n* Inflammatory rheumatic diseases (rheumatoid arthritis, Psoriatic arthritis, etc.)\n* Widespread or generalized pain syndrome (e.g. fibromyalgia)\n* Lumbar or cervical nerve root compression\n* Poly-arthrosis resulting in joint replacement surgery\n* Any other condition or impairment that, in the opinion of the investigator, makes a potential participant unsuitable for participation or which obstruct participation",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}